Search Results 1711-1720 of 16403 for Maximum

  1. Study of Pembrolizumab (MK-3475) in Participants With Progressive Locally Advanced or Metastatic Carcinoma, Melanoma, or Non-small Cell Lung Carcinoma (P07990/MK-3475-001/KEYNOTE-001) - Mayo Clinic

    This study will be done in 6 parts. In Part A the dose of intravenous (IV) pembrolizumab (MK-3475) will be escalated to find the maximum tolerated dose (MTD) ...

  2. Mayo Clinic Minute + Video: Is Himalayan sea salt a healthy alternative?

    Is Himalayan sea salt better for your heart health? Is Himalayan pink salt a healthy alternative? What is the healthiest type of salt?

  3. Study to Assess the Effectiveness and Safety of Ublituximab + TGR-1202 With or Without Bendamustine and TGR-1202 Alone to Treat Patients with Previously Treated Non-Hodgkins Lymphoma - Mayo Clinic

    0 – FL, SLL and MZL subjects - Treatment naïve or previously treated with a maximum of two prior lines of therapy (excluding antibiotics); FL subjects must ...

  4. A Study to Evaluate the Safety and Effectiveness of Intratumoral and Intravenous Injection of Vesicular Stomatitis Virus Expressing Human Interferon Beta, and Tyrosinase Related Protein 1 (VSV-IFNb-TYRP1) in Patients with Metastatic Ocular Melanoma and Previously Treated Patients with Unresectable Stage III/IV Cutaneous Melanoma - Mayo Clinic

    The purpose of this study is to determine the safety profile and maximum tolerated dose (MTD) of VSV-IFNß-TYRP1 therapy when administered by IV and IT injection ...

  5. Ph 1b Study to Evaluate GSK2110183 in Combination with Bortezomib and Dexamethasone in Subjects with Multiple Myeloma - Mayo Clinic

    Part 1 will identify the maximum tolerated dose(s) (MTD) of the combination regimen. Schedule A - GSK2110183 administered once daily with bortezomib (1.3 mg ...

  6. A Study to Evaluate Autologous Bone Marrow Mononuclear Cells Using the CardiAMP™ Cell Therapy in Patients With Post Myocardial Infarction Heart Failure - Mayo Clinic

    The purpose of this study is to compare treatment with the CardiAMP cell therapy to a sham treatment. A roll-in phase with a maximum of 10 subjects will precede ...

  7. Mayo Clinic clinical trials in patients with tumor-induced osteomalacia

    Whole body maximum intensity projection, CT, and fused PET/CT images from a Gallium 68 (68Ga)-DOTATATE PET/CT demonstrate a calcified mass in the right ...

  8. Study of RP-3500 With Niraparib or Olaparib in Advanced Solid Tumors - Mayo Clinic

    ... maximum tolerated dose (MTD) of RP-3500 in combination with Niraparib or Olaparib, examine pharmacokinetics (PK) and assess anti-tumor activity.

  9. A Study of NB003 in Patients With Advanced Malignancies - Mayo Clinic

    longer, up to a maximum wash-out period of 21 days prior to the initiation of study drug administration. 2. Major surgery within 4 weeks of the first dose ...

  10. VE303 for Prevention of Recurrent Clostridioides Difficile Infection - Mayo Clinic

    Receive and complete a course of SoC antibiotic therapy for at least 10 days, up to a maximum of 21 days (Note: choice of agent is at the physician's ...